Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.

Researchers have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse.

Scientists have carried out the first ever genome scan for womb cancer and discovered a genetic region that reduces risk of the disease, according to a Cambridge study published in Nature Genetics on Sunday, 17 April.

Researchers in the Department of Pathology have established precisely how the ‘cutting and pasting’ of genetic material from one chromosome to another results in cancer.

Cambridge scientists are asking what role stem cells play in how cancer develops, spreads and relapses.

Can better decisions be made about which anticancer drugs to progress to clinical trials?

Scientists at Strangeways Research Laboratory are leading the search for the ‘genetic cards’ that determine an individual’s risk of cancer.

Cancer cells can now be viewed as never before, thanks to cutting-edge imaging tools being developed in Cambridge.

Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.

Professor Sir Bruce Ponder describes the vision of a Cambridge-wide initiative to link world-class cancer research to improved patient care.